A detailed history of Meeder Asset Management Inc transactions in Charles River Laboratories International, Inc. stock. As of the latest transaction made, Meeder Asset Management Inc holds 27 shares of CRL stock, worth $4,463. This represents 0.0% of its overall portfolio holdings.

Number of Shares
27
Holding current value
$4,463
% of portfolio
0.0%

Shares

25 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Feb 12, 2025

BUY
$178.58 - $220.69 $4,821 - $5,958
27 New
27 $4,000
Q2 2024

Aug 08, 2024

SELL
$206.39 - $268.73 $62,742 - $81,693
-304 Reduced 90.75%
31 $6,000
Q1 2024

May 07, 2024

SELL
$203.52 - $273.43 $111,121 - $149,292
-546 Reduced 61.98%
335 $90,000
Q1 2023

May 15, 2023

BUY
$191.89 - $259.92 $169,055 - $228,989
881 New
881 $177,000
Q3 2022

Nov 14, 2022

SELL
$182.44 - $250.54 $23,534 - $32,319
-129 Reduced 45.1%
157 $31,000
Q2 2022

Aug 08, 2022

SELL
$204.13 - $302.4 $27,965 - $41,428
-137 Reduced 32.39%
286 $61,000
Q1 2022

May 10, 2022

SELL
$255.51 - $362.11 $287,959 - $408,097
-1,127 Reduced 72.71%
423 $120,000
Q4 2021

Feb 11, 2022

SELL
$351.38 - $448.68 $56,572 - $72,237
-161 Reduced 9.41%
1,550 $585,000
Q3 2021

Nov 08, 2021

SELL
$372.64 - $458.3 $282,461 - $347,391
-758 Reduced 30.7%
1,711 $707,000
Q2 2021

Aug 09, 2021

BUY
$294.17 - $371.65 $6,471 - $8,176
22 Added 0.9%
2,469 $913,000
Q1 2021

Apr 28, 2021

BUY
$249.67 - $299.48 $599,457 - $719,051
2,401 Added 5219.57%
2,447 $710,000
Q4 2020

Feb 09, 2021

SELL
$222.0 - $252.62 $667,110 - $759,123
-3,005 Reduced 98.49%
46 $11,000
Q3 2020

Nov 02, 2020

BUY
$175.56 - $226.45 $394,658 - $509,059
2,248 Added 279.95%
3,051 $692,000
Q2 2020

Aug 11, 2020

SELL
$118.84 - $189.72 $2,614 - $4,173
-22 Reduced 2.67%
803 $140,000
Q1 2020

May 15, 2020

BUY
$98.9 - $178.34 $39,658 - $71,514
401 Added 94.58%
825 $105,000
Q4 2019

Feb 13, 2020

BUY
$126.05 - $152.76 $630 - $763
5 Added 1.19%
424 $65,000
Q3 2019

Oct 17, 2019

BUY
$125.07 - $143.67 $1,375 - $1,580
11 Added 2.7%
419 $56,000
Q2 2019

Aug 05, 2019

BUY
$123.4 - $148.55 $987 - $1,188
8 Added 2.0%
408 $58,000
Q1 2019

Apr 16, 2019

SELL
$104.82 - $146.73 $103,771 - $145,262
-990 Reduced 71.22%
400 $58,000
Q4 2018

Jan 17, 2019

BUY
$105.09 - $137.23 $55,067 - $71,908
524 Added 60.51%
1,390 $157,000
Q3 2018

Nov 02, 2018

BUY
$112.11 - $134.54 $20,628 - $24,755
184 Added 26.98%
866 $0
Q2 2018

Jul 24, 2018

SELL
$102.37 - $117.25 $5,425 - $6,214
-53 Reduced 7.21%
682 $0
Q1 2018

May 03, 2018

SELL
$98.19 - $115.2 $86,014 - $100,915
-876 Reduced 54.38%
735 $78,000
Q4 2017

Feb 02, 2018

SELL
$100.43 - $118.09 $415,679 - $488,774
-4,139 Reduced 71.98%
1,611 $176,000
Q3 2017

Oct 20, 2017

BUY
$96.72 - $109.26 $556,140 - $628,245
5,750
5,750 $622,000

Others Institutions Holding CRL

About CHARLES RIVER LABORATORIES INTERNATIONAL, INC.


  • Ticker CRL
  • Exchange NYSE
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 50,863,300
  • Market Cap $8.41B
  • Description
  • Charles River Laboratories International, Inc., a non-clinical contract research organization, provides drug discovery, non-clinical development, and safety testing services in the United States, Europe, Canada, the Asia Pacific, and internationally. It operates through three segments: Research Models and Services (RMS), Discovery and Safety Ass...
More about CRL
Track This Portfolio

Track Meeder Asset Management Inc Portfolio

Follow Meeder Asset Management Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Meeder Asset Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Meeder Asset Management Inc with notifications on news.